09/27/2019 / By Melissa Smith
A study published in the Annals of Agricultural and Environmental Medicine investigated the cardiovascular health of children treated for acute lymphoblastic leukemia. This study was carried out by a team of researchers at the Medical University of Lublin in Poland.
Taken together, the findings of the study indicated that individuals treated for leukemia during childhood are at a greater risk of prematurely developing atherosclerosis.
Read the full text of the study at this link.
For more studies on the heart health of childhood cancer survivors, visit HeartDisease.news.
Journal Reference:
Sadurska E, Zaucha-Pra?mo A, Brodzisz A, Kowalczyk J, Ben-Skowronek I. PREMATURE ATHEROSCLEROSIS AFTER TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDHOOD. Annals of Agricultural and Environmental Medicine. 2018; 25(1): 71–76. DOI: DOI: 10.5604/12321966.1230680
Tagged Under: acute lymphoblastic leukemia, antineoplastic therapy, atherosclerosis, Big Pharma, cardiovascular disease, children's health, dangerous drugs, harmful medicine, heart disease, leukemia, research
COPYRIGHT © 2017 BIG PHARMA NEWS